CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer

Figure 2

Kaplan-Meier analysis for progression-free survival comparing high and low CD73 expression. The log-rank test was used for the detection of statistical significance.